NCT02212002View on ClinicalTrials.gov

Effect of Intrapartum Antibiotic Prophylaxis (IAP) on the Development of the Neonatal Gut Microbiota.

CompletedOBSERVATIONAL
Enrollment

84

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

August 31, 2014

Conditions
Microbiota
Interventions
DRUG

IAP

maternal IAP, consisting of intravenous ampicillin given every 4 hours until delivery (first dose 2 g, following doses 1 g each).

Trial Locations (1)

40138

Nursery, S.Orsola-Malpighi Hospital, Bologna

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

NCT02212002 - Effect of Intrapartum Antibiotic Prophylaxis (IAP) on the Development of the Neonatal Gut Microbiota. | Biotech Hunter | Biotech Hunter